[Effect of IKK2 Inhibitor LY2409881 on Diffuse Large B-Cell Lymphoma Cell Apoptosis and Its Mechanism]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Aug;26(4):1086-1092. doi: 10.7534/j.issn.1009-2137.2018.04.024.
[Article in Chinese]

Abstract

Objective: To investigate the effects and its potential mechanism of IKK2 inhibitor LY2409881 on proliferation, cell cycle and apoptosis of diffuse large B-cell lymphoma (DLBCL) cell lines.

Methods: CCK8 assay was used to detect the effect of LY2409881 on proliferation of DLBCL cell lines; Flow cytometry was used to analyze cell cycle; Western blot was used to analyze apoptosis and its potential mechanism.

Results: LY2409881 inhibited the proliferation of multiple DLBCL cell lines obviously, and caused G1 cell arrest. Furtherly, LY2409881 inhibited the expression of c-FLIP, induced the activation of DR4 and caspase 8. Meanwhile, LY2409881 induced the expression of pro-apoptotic protein BAX and inhibited the expression of anti-apoptotic protein MCL-1 and BCL-2.

Conclusion: LY2409881 inhibits the proliferation of DLBCL cell lines, causes G1 cell arrest and induces apoptosis via the endogenous and exogenous apoptotic pathways.

MeSH terms

  • Apoptosis
  • Cell Line, Tumor
  • Cell Proliferation
  • Humans
  • I-kappa B Kinase
  • Lymphoma, Large B-Cell, Diffuse*
  • Pyrimidines
  • Thiophenes

Substances

  • LY2409881
  • Pyrimidines
  • Thiophenes
  • I-kappa B Kinase
  • IKBKB protein, human